- Global Pharma News & Resources

PNEUMOCOCCAL TESTING MARKET TAXONOMY– Latest Scenario Report with Forecast by 2028

Having surpassed the global market valuation of US$1 billion in 2019, the demand for pneumococcal testing continues to soar. A new study projects that the global pneumococcal testing market will exhibit a double-digit CAGR during the forecast period (2020 – 2030). These insights are based on a report on Pneumococcal Testing Market by Future Market Insights.

Enhanced focus on accuracy and reliability of pneumococcal testing continues to shape the market. As reliability of diagnostic tests remain the backbone of pathogen-directed treatment, increased emphasis on enhanced patient care is driving the growth of pneumococcal testing market. Proliferation of diagnostic tests in both developing and developed economies is the growth engine of pneumococcal testing market, according to a new study of Future Market Insights (FMI). The study finds that global pneumococcal testing market surpassed a billion-dollar revenues in 2019. Prolific demand for analyzers is stimulating market growth, with consumables closing in. Moreover, immunofluorescence is gaining paramount importance in pneumococcal testing market.

“Notable players must divert substantial pecuniary resources towards their key forte i.e. research and development along with strategic acquisitions for robust competitive position in pneumococcal testing market,” concludes the FMI report.

Request report sample with 200+ pages to gain in-depth market insights at

Pneumococcal Testing Market – Key Takeaways

  • Owing to real-time diagnostic features, Point of Care (POC) testing is gaining popularity in recent years.
  • Greater availability of skilled personnel and pneumococcal testing kits is driving the adoption in hospitals and clinics, the prominent end-use area.
  • High specificity and sensitivity of Enzyme Linked Immunosorbent Assay (ELISA) is fuelling its usage among consumers across the globe.
  • Majority of gains in pneumococcal testing market will be concentrated in Europe and North America, collectively accounting for 50% revenue share.

Pneumococcal Testing Market – Key Driving Factors

  • Greater prevelance of diseases such as meningitis, bacteremia, and pneumonia is augmenting the demand for pneumococcal testing.
  • Higher case-fatality rate in geriatric population is supporting the growth of pneumococcal testing market.
  • Technological advancements in Nucleic Acid Detection Tests (NATs) for timely detection of pathogens has augured well for market.
  • Introduction of molecular diagnostic testing in developing countries is complementing regional market growth.

Pneumococcal Testing Market – Key Restraints

  • Global pneumococcal testing market is consolidated by top three players, making it difficult for emerging players to expand their market share.
  • Diversion of leading players towards developing and testing COVID-19 test kits are limiting the market growth.

Contact Sales for Further Assistance in Purchasing this Report@

Impact of COVID-19 on Pneumococcal Testing Market

The global pneumococcal testing market is projected to expand on the back of ongoing COVID-19 pandemic. Being one of the leading causes of mortality among children, pneumococcal testing is necessary for identifying the vulnerable groups during the widespread outbreak. Moreover, immunization programs, led by WHO and UNICEF are propelling the demand for pneumococcal testing. However, the market may witness a brief slowdown as leading pharmaceutical companies, vaccine developers, and research institutes are currently focused on creating a vaccine for COVID-19. The market will regain its pace once the pandemic begins to recede.

Competition Analysis

Some of the prominent companies in global pneumococcal testing market that are profiled in this FMI report include, but are not limited to, Abbott Laboratories, F-Hoffman la Roche Ltd, and Thermo Fisher Scientific Inc. Established players continue to do extensive research and development to offer more accurate testing. Prevention and timely detection will be the new fundamentals of future healthcare systems. Hence, all major strategies of industry leaders will be aligned towards that principle. Moreover, key companies will channel substantial resources towards syndromic screening approach, and point of care infection control. Strategic acquisition remains key collaborative approach of market leaders as well. For instance, Thermo Fisher Scientific Inc. acquired QIAGEN N.V. in March 2020 which strengthened R&D expertise and industry-leading capabilities of both companies.

Explore the global pneumococcal testing market report with 218 illustrative figures, 52 data tables and the table of contents. Request ToC of the report at

More About the Report

The FMI’s market research report of 287 pages offers comprehensive insights on pneumococcal testing market. The market is analyzed on the basis of method (immunodiagnostics, molecular diagnostic, and point of care testing), technology (immunofluorescence, enzyme linked immunosorbent assay, western blot test, nucleic acid sequence based amplification, immunohistochemistry, and polymerase chain reaction), product type (consumables, analyzers), and end users (hospitals, ambulatory surgical centers, and clinics) across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa).

Explore Extensive Coverage of FMI’s Healthcare, Pharmaceuticals and Medical Devices Landscape

Digital Pathology Market – Find detailed insights on the global digital pathology market with in-depth segment-wide analysis, critical developmental strategies, prominent players, key influencing factors, and market statistics for 10-year forecast period.

Generic Injectable Market – FMI’s report on the global generic injectable market offers comprehensive insights on the market poised for promising growth during 2019-2029. The study covers extensive analysis of prominent leaders, revenue sources, and key restraining forces.

PARP Inhibitors Market – Get a deep-dive analysis on the global PARP inhibitors market with incisive insights on key forte of industry players, regional market forecast, regulatory policies, restraints, opportunities, and growth levers for the course of forecast period (2019-2026).

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:
Press Release Source:

Editor Details

Last Updated: 11-Mar-2021